The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start.
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start.
Rural Health Transformation Program funding gives states broad flexibility and may help address longstanding access gaps.
What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps.
Here’s what healthcare entities should know about the maturing landscape, what to actually be concerned about, and the next stage of healthcare data evolution as we know it.
The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency as any other critical performance domain.
New 3D printed technology makes lower extremity surgeons architects of restoration, not adaptation.
This is not an argument against capital in independent medicine. Practices need infrastructure, and physicians have legitimate reasons to seek liquidity. It is an argument that the exit stage carries a risk this market has not yet priced.
If we do not get this right, we may inadvertently cause a new sarcopenia epidemic while congratulating ourselves on solving obesity.
We are moving into an era where we can finally converse with our data. We can ask, "Why are denials spiking in Region X?" or "Show me the safety profile of this cohort," and receive an answer, not a spreadsheet.
The FDA now treats continuous, real-time data sharing as a regulatory direction of travel rather than a theoretical future. The neurology field should pay close attention.
You cannot secure what you cannot see, and right now, healthcare organizations are accumulating hidden cyber liabilities with every keystroke.
Matching the right patient to the right therapy now requires understanding what’s driving the apnea, not just how often it occurs. Closing that gap means rethinking what sleep apnea testing identifies and where it happens.
It usually tracks some version of value delivered, where more customers lead to more usage and more revenue. However, in healthcare, the blind pursuit of revenue can cause real harm.
The PBM reform efforts are directional, not temporary. Meeting these expectations requires automated systems that can reconstruct claim logic on demand and provide real-time alignment between pricing, rebates and financial outputs.
Healthcare cybersecurity is no longer just about protecting electronic health records. It is increasingly about protecting the research, algorithms, clinical data, and intellectual property that drive the next generation of medicine.